Strategic Advocates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-103
Closed -$8.58K 399
2025
Q4
$8.58K Hold
103
﹤0.01% 385
2025
Q3
$7.74K Buy
+103
New +$7.68K ﹤0.01% 372

Other funds holding GEHC

Strategic Advocates's GEHC Position: Q1 2026 in Review

Strategic Advocates sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 103 shares — an estimated $8.58K sold.

Strategic Advocates first reported a position in GEHC in Q3 2025 and held it in 2 quarters. The position peaked at $8.58K in Q4 2025. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Strategic Advocates reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Strategic Advocates sold 103 GE HealthCare shares in Q1 2026, an estimated $8.58K.
  • Strategic Advocates first reported a position in GE HealthCare in Q3 2025 and held it in 2 quarters.
  • Strategic Advocates's GE HealthCare position peaked at $8.58K in Q4 2025.
  • 1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.